ICARES Medicus (ROCO:6612) FCF Margin %: -4.10% (As of Dec. 2025)

What is ICARES Medicus FCF Margin %?

ICARES Medicus ROCO:6612 +1.13% 84 FCF Margin % is -4.10% as of Dec. 2025. GuruFocus rates ROCO:6612 with a GF Score™ of 84/100 and a GF Value™ of NT$188.59 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, ICARES Medicus ranks worse than 65.4% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ICARES Medicus's Free Cash Flow for the three months ended in Dec. 2025 was NT$-12 Mil. ICARES Medicus's Revenue for the three months ended in Dec. 2025 was NT$301 Mil. Therefore, ICARES Medicus's FCF Margin % for the quarter that ended in Dec. 2025 was -4.10%.

As of today, ICARES Medicus's current FCF Yield % is -3.31%.

The historical rank and industry rank for ICARES Medicus's FCF Margin % or its related term are showing as below:

ROCO:6612' s FCF Margin % Range Over the Past 10 Years
Min: -23.87 Med: 8.91 Max: 18.54
Current: -9.93

During the past 13 years, the highest FCF Margin % of ICARES Medicus was 18.54%. The lowest was -23.87%. And the median was 8.91%.

ROCO:6612's FCF Margin % is ranked worse than
65.4% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.34 vs ROCO:6612: -9.93

ICARES Medicus FCF Margin % Related Terms

ICARES Medicus FCF Margin % Historical Data

* Premium members only.

The historical data trend for ICARES Medicus's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICARES Medicus FCF Margin % Chart

ICARES Medicus Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

8.15

18.54

-16.89

-23.87

-9.93

ICARES Medicus Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
FCF Margin %	Get a 7-Day Free Trial															-21.30	-34.09	33.82	-33.97	-4.10

ROCO:6612 vs ISRG, BDX, MDLN: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, ICARES Medicus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ICARES Medicus FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ICARES Medicus's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ICARES Medicus's FCF Margin % falls into.

Save Embed

84GF Score

ICARES Medicus Inc ROCO:6612

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ICARES Medicus FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ICARES Medicus's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-112.306	/	1130.986
	=	-9.93 %

ICARES Medicus's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-12.337	/	300.561
	=	-4.10 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -4.10% mean?

ICARES Medicus (ROCO:6612) has a FCF Margin % of -4.10% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ICARES Medicus and its competitors. According to the industry distribution chart, ICARES Medicus ranks #533 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 65.4%.

Is ICARES Medicus' FCF Margin % too high?

ICARES Medicus' current FCF Margin % is -4.10%. Based on the distribution chart, ICARES Medicus ranks #533 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ICARES Medicus has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does ICARES Medicus' FCF Margin % compare to ISRG and BDX?

According to the Medical Devices & Instruments industry distribution chart, ICARES Medicus ranks #533 out of 815 companies for FCF Margin %. This places ICARES Medicus in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Medical Devices & Instruments company?

A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ICARES Medicus and its competitors. ICARES Medicus's current FCF Margin % is -4.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ICARES Medicus stock overvalued right now?

Based on GuruFocus' analysis, ICARES Medicus (ROCO:6612) is currently considered Possible Value Trap. The stock's GF Value™ is NT$188.59, compared to a current price of NT$71.60 — trading 62% below its estimated fair value. The current FCF Margin % is -4.10%. ICARES Medicus' overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For ICARES Medicus (ROCO:6612), the current FCF Margin % is -4.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ICARES Medicus (ROCO:6612) Overvalued in 2026?

Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued. The current stock price of NT$71.60 is trading 62% below its estimated GF Value™ of NT$188.59. GuruFocus considers ICARES Medicus to be Possible Value Trap.

Key valuation signals for ROCO:6612:

FCF Margin %: -4.10%
GF Value™: NT$188.59 vs. price of NT$71.60 (62% below fair value)
GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ICARES Medicus Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TPE:1752 TPE:1783 TPE:1786 TPE:4737 ROCO:1565 ROCO:6527 ROCO:4111 ROCO:4116 ROCO:6730 ROCO:5312 ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543

Address Section 2, Shengyi Road, No. 16, 4th Floor, Hsinchu County, Zhubei, TWN, 30261

Website https://www.icaresmedicus.com

ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.

84GF Score

Get the complete analysis for ROCO:6612

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.60

Price

NT$188.59

GF Value

View ROCO:6612 Analysis

See FCF Margin % data for all stocks →